+ Site Statistics
References:
52,654,530
Abstracts:
29,560,856
PMIDs:
28,072,755
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn

+ Translate
+ Recently Requested

Sino-orbital aspergillosis treated with combination antifungal therapy. Successful therapy after failure with amphotericin B and surgery



Sino-orbital aspergillosis treated with combination antifungal therapy. Successful therapy after failure with amphotericin B and surgery



JAMA 244(8): 814-815



The case is presented of a 37-yr-old man with Aspergillus fumigatus sinus infection that showed malignant progression despite surgery, treatment with amphotericin B and the results of in vitro susceptibility testing for the fungus involved.

(PDF emailed within 1 workday: $29.90)

Accession: 000980601

Download citation: RISBibTeXText

PMID: 6248652



Related references

Combination antifungal therapy of murine aspergillosis: liposomal amphotericin B and micafungin. Journal of Antimicrobial ChemoTherapy 52(4): 656-662, 2003

Successful therapy of progressive rhino-orbital mucormycosis caused by Rhizopus arrhizus with combined and sequential antifungal therapy, surgery and hyperbaric therapy. Medical Mycology Case Reports 6: 51-54, 2014

Combination antifungal therapy with FK463 plus amphotericin B in treatment of experimental pulmonary aspergillosis. Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 39: 581, 1999

Sequential or combination antifungal therapy with voriconazole and liposomal amphotericin B in a Guinea pig model of invasive aspergillosis. Antimicrobial Agents and ChemoTherapy 50(4): 1567-1569, 2006

Efficacy of combination antifungal therapy with intraperitoneally administered micafungin and aerosolized liposomal amphotericin B against murine invasive pulmonary aspergillosis. Antimicrobial Agents and ChemoTherapy 53(8): 3508-3510, 2009

Invasive esophageal aspergillosis associated with acute myelogenous leukemia: successful therapy with combination caspofungin and liposomal amphotericin B. Pediatric Hematology and Oncology 24(1): 63-68, 2006

Successful treatment of rhino-orbital mucormycosis by a new combination therapy with liposomal amphotericin B and micafungin. Auris, Nasus, Larynx 39(2): 224-228, 2012

The strategy of following voriconazole vs amphotericin B with other licensed antifungal therapy for primary therapy of invasive aspergillosis. Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 43: 446, 2003

Open, randomised comparison of voriconazole and amphotericin B followed by other licensed antifungal therapy for primary therapy of invasive aspergillosis. Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 41: 378, 2001

Successful treatment with micafungin of invasive pulmonary aspergillosis in acute myeloid leukemia, with renal failure due to amphotericin B therapy. Annals of Hematology 83(1): 64-66, 2003

Novel antifungal agents as salvage therapy for invasive aspergillosis in patients with hematologic malignancies: posaconazole compared with high-dose lipid formulations of amphotericin B alone or in combination with caspofungin. Leukemia 22(3): 496-503, 2007

Strategy of following voriconazole versus amphotericin B therapy with other licensed antifungal therapy for primary treatment of invasive aspergillosis: impact of other therapies on outcome. Clinical Infectious Diseases 41(10): 1448-1452, 2005

Successful allogeneic stem cell transplantation in two patients with acute myelogenous leukaemia and invasive aspergillosis by antifungal combination therapy. Mycoses 54(4): E255-E259, 2011

Massive intracerebral aspergillosis responding to combination high dose liposomal amphotericin B and cytokine therapy without surgery. Journal of Medical Microbiology 51(1): 70-75, 2002

Sino orbital and cerebral aspergillosis cure with medical therapy. Mykosen 30(8): 379-385, 1987